Literature DB >> 6390185

Immunoreactive levels of myosin light-chain kinase in normal and virus-transformed chicken embryo fibroblasts.

L J Van Eldik, D M Watterson, W H Burgess.   

Abstract

Calmodulin, a calcium-modulated effector protein, is an important mediator of the intracellular actions of calcium through its interaction with calmodulin-binding proteins. We report here that the immunoreactive levels of a calmodulin-binding protein, myosin light-chain kinase, are decreased in transformed chicken embryo fibroblasts.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6390185      PMCID： PMC369042          DOI： 10.1128/mcb.4.10.2224-2226.1984

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN： 0270-7306            Impact factor:   4.272


  10 in total

1.  Composition of the myosin light chain kinase from chicken gizzard.

Authors:  R Dabrowska; D Aromatorio; J M Sherry; D J Hartshorne
Journal:  Biochem Biophys Res Commun       Date:  1977-10-24       Impact factor: 3.575

2.  Calcium-dependent regulatory protein of cyclic nucleotide metabolism in normal and transformed chicken embryo fibroblasts.

Authors:  D M Watterson; L J Van Eldik; R E Smith; T C Vanaman
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

3.  Substrate specificity of liver calmodulin-dependent glycogen synthase kinase.

Authors:  C M Schworer; T R Soderling
Journal:  Biochem Biophys Res Commun       Date:  1983-10-31       Impact factor: 3.575

4.  Biosynthesis of calmodulin in normal and virus-transformed chicken embryo fibroblasts.

Authors:  J G Zendegui; R E Zielinski; D M Watterson; L J Van Eldik
Journal:  Mol Cell Biol       Date:  1984-05       Impact factor: 4.272

5.  Phosphorylation of smooth muscle myosin light chain by five different kinases.

Authors:  T J Singh; A Akatsuka; K P Huang
Journal:  FEBS Lett       Date:  1983-08-08       Impact factor: 4.124

6.  Purification of smooth muscle myosin light-chain kinase.

Authors:  R S Adelstein; C B Klee
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

7.  Analytical subcellular distribution of calmodulin and calmodulin-binding proteins in normal and virus-transformed fibroblasts.

Authors:  L J Van Eldik; W H Burgess
Journal:  J Biol Chem       Date:  1983-04-10       Impact factor: 5.157

Review 8.  Regulatory mechanisms in the control of protein kinases.

Authors:  D A Flockhart; J D Corbin
Journal:  CRC Crit Rev Biochem       Date:  1982-02

9.  Reproducible production of antiserum against vertebrate calmodulin and determination of the immunoreactive site.

Authors:  L J Van Eldik; D M Watterson
Journal:  J Biol Chem       Date:  1981-05-10       Impact factor: 5.157

10.  Human platelet myosin light chain kinase requires the calcium-binding protein calmodulin for activity.

Authors:  D R Hathaway; R S Adelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205
  10 in total
  4 in total

1.  A mutant Paramecium with a defective calcium-dependent potassium conductance has an altered calmodulin: a nonlethal selective alteration in calmodulin regulation.

Authors:  W H Schaefer; R D Hinrichsen; A Burgess-Cassler; C Kung; I A Blair; D M Watterson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

2.  Deficiency in myosin light-chain phosphorylation causes cytokinesis failure and multipolarity in cancer cells.

Authors:  Q Wu; R M Sahasrabudhe; L Z Luo; D W Lewis; S M Gollin; W S Saunders
Journal:  Oncogene       Date:  2010-05-24       Impact factor: 9.867

3.  Use of DNA sequence and mutant analyses and antisense oligodeoxynucleotides to examine the molecular basis of nonmuscle myosin light chain kinase autoinhibition, calmodulin recognition, and activity.

Authors:  M O Shoemaker; W Lau; R L Shattuck; A P Kwiatkowski; P E Matrisian; L Guerra-Santos; E Wilson; T J Lukas; L J Van Eldik; D M Watterson
Journal:  J Cell Biol       Date:  1990-09       Impact factor: 10.539

Review 4.  Myosins as fundamental components during tumorigenesis: diverse and indispensable.

Authors:  Yan-Ruide Li; Wan-Xi Yang
Journal:  Oncotarget       Date:  2016-07-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.